0.00
—
Close of 30 Oct 2026, in USD
About Deltagen
Its shares trade under the ticker DGEN. It has been listed since 3 August 2000. In the fiscal year to 31 December 2015, it reported revenue of $770,000 and a net loss of $46,000. At that date it held total assets of $1.8m and shareholders' equity of $1.7m.
Deltagen, Inc. engages in the provision of drug discovery tools and services to the biopharmaceutical industry. The company is headquartered in San Mateo, California. The company went IPO on 2000-08-03. The firm offers a suite of programs designed to manage the efficiency of drug discovery, including access to biological models, as well as both small-molecule and secreted protein drug targets. In addition, it offers target validation data in the areas of immunology and metabolic diseases. The firm's biology approach is designed to help clear the first and major hurdle of drug target discovery: lead validation. Its DeltaBase is a searchable database of in vivo-derived mammalian gene function information and gene targets. DeltaOne from the Company provides per-gene access to the knockout mice and/or phenotypic data needed.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 3 Aug 2000
- Employees
- 268
Leadership
Pay as last reported
- Dr. Constantine AnagnostopoulosChairman of the Board, since 2001
- Mr. Larry HillChief Executive Officer
- Mr. Daniel RattoChief Financial Officer
- Dr. Geoffrey YarrantonExecutive Vice President of Research and Development
- Dr. Donald KaranewskySenior Vice President and New Site Director of Deltagen Research Laboratories
- Mr. Terry ColeyVice President of Information Technology$239,100
- Mr. John BurkeSenior Vice President-Intellectual Property, General Counsel$241,500
- Dr. Mark MooreChief Scientific Officer and Treasurer$304,000
- Dr. Peter MyersExecutive Vice President of Deltagen Research Laboratories
- Mr. Augustine YeeSenior Vice President-Corporate Development, Secretary$237,300
- Mr. David BeierDirector
- Mr. Thomas PennDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Deltagen Inc has a strong portfolio of innovative products that cater to a wide range of industries. These products are highly regarded for their quality and reliability, giving the company a competitive edge.
- The company boasts a talented and experienced team that is capable of developing and delivering high-tech solutions to meet customer needs. This expertise enables Deltagen Inc to stay at the forefront of technological advancements in its target markets.
Weaknesses
- One of the weaknesses faced by Deltagen Inc is its heavy reliance on a few major clients for a significant portion of its revenue. This dependence exposes the company to potential risks if these clients were to reduce or terminate their business partnerships.
- Another weakness is the company's limited geographic reach. Deltagen Inc primarily operates in a specific region, which restricts its ability to tap into new markets and diversify its customer base.
Opportunities
- There are several opportunities for Deltagen Inc to explore. With the increasing demand for its products globally, the company can expand its operations into new geographical areas, opening up the potential for significant growth.
- Furthermore, the growing emphasis on sustainable and eco-friendly solutions presents a chance for Deltagen Inc to develop and market innovative green technologies, capitalizing on the market trend and establishing itself as an industry leader.
Threats
- One of the major threats Deltagen Inc faces is intense competition from both existing players and new entrants in the market. To maintain its market position, the company needs to continuously invest in research and development, product improvement, and marketing efforts.
- Another threat comes from changes in government regulations and policies. Deltagen Inc must closely monitor and adapt to any regulatory changes to ensure compliance and avoid potential disruptions to its business operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.